Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
515.00    -5.00 (-0.96%)
Bid:
510.00
Ask:
520.00
Spread: 10.00 (1.961%)
Market Cap: £84.49m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Full Year Trading Statement

26 Jan 2022 07:00

RNS Number : 6308Z
Anpario PLC
26 January 2022
 
Anpario plc("Anpario" or the "Group")

 

Full Year Trading Statement

 

Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2021.

 

Trading update

The Group has delivered a strong operating performance despite a number of challenges in global markets and supply chains due to the pandemic. Earnings are expected to be in line with current market expectations with full year sales expected to be not less than £33m.

 

Sales growth has been achieved across all of our regions, Asia, Europe, Middle-East and Africa (MEA) and the Americas. Some territories are still experiencing weakness linked to the pandemic, particularly in parts of MEA and Asia. However, a number of key market developments have provided MEA with the strongest segment growth, helping it recover from the previous year. The impact in Asia of lock-downs and reduced tourism was more than offset by strong performances in China and Australasia.

 

We have continued to experience increased logistics and raw material price inflation, the cost of which is being passed on through sales price increases. We are seeing some encouraging signs that cost price inflation has begun to stabilise and the improving international travel situation will help our sales teams drive new business development initiatives.

 

The Board would like to thank all stakeholders, especially our staff around the world, who have adapted to new ways of working and put every effort into ensuring continued production and delivery of our products to customers and our subsidiaries around the world.

 

Financial position

Our financial position remains very strong with year-end cash balances of £15.5m (31 Dec 2020: £15.8m). Global logistics challenges led us to absorb cash into working capital, particularly through the first part of the year, to ensure local supply to our customers. Through H2 we have increased cash by £0.9m, after £2.1m of dividend payments and further capital investments of £0.9m, including the Solar Panel installation to reduce our carbon emissions.

 

Final results date

The Group expects to announce its final results for the year ended 31 December 2021 on 16 March 2022.

 

 

Enquiries:

 

Anpario plc

Richard Edwards, CEO

+44(0) 777 6417 129

Marc Wilson, Group Finance Director

+44(0) 1909 537380

 

Peel Hunt LLP (Nomad and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Lalit Bose

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUGGGUPPPPA
Date   Source Headline
5th Feb 20205:14 pmRNSShare Buyback Programme
5th Feb 20209:00 amRNSDirector/PDMR Shareholding
30th Jan 20203:51 pmRNSBlock Listing Application
30th Jan 20207:00 amBUSTrading Statement
20th Jan 202010:05 amRNSHolding(s) in Company
17th Jan 20204:55 pmRNSBlock listing Interim Review
17th Jan 20209:40 amRNSHolding(s) in Company
13th Jan 202010:31 amRNSHolding(s) in Company
8th Jan 20203:39 pmRNSHolding(s) in Company
6th Jan 202011:04 amRNSHolding(s) in Company
18th Nov 20195:30 pmRNSHolding(s) in Company
5th Nov 20199:44 amRNSHolding(s) in Company
11th Sep 20197:00 amBUSHalf-year Report
14th Aug 201911:10 amRNSHolding(s) in Company
13th Aug 20196:08 pmRNSHolding(s) in Company
17th Jul 201910:41 amRNSBlock listing Interim Review
27th Jun 20194:23 pmRNSResult of AGM
27th Jun 20197:00 amRNSAGM Statement
21st Jun 20197:00 amRNSTotal Voting Rights
5th Jun 201910:47 amRNSDirector/PDMR Shareholding
4th Jun 20195:35 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20193:27 pmRNSHolding(s) in Company
17th Apr 20192:04 pmRNSHolding(s) in Company
2nd Apr 201910:33 amRNSTotal Voting Rights
8th Mar 201911:06 amRNSFinal Results
6th Mar 20197:00 amBUSFinal Results
5th Mar 20194:17 pmRNSTotal Voting Rights
29th Jan 20197:00 amRNSPre-Close Trading Statement
17th Jan 201912:17 pmRNSBlock listing Interim Review
6th Dec 20182:30 pmRNSHolding(s) in Company
6th Dec 20182:25 pmRNSHolding(s) in Company
2nd Oct 20183:51 pmRNSTotal Voting Rights
5th Sep 20187:00 amRNSHalf-year Report
31st Jul 20189:54 amRNSHolding(s) in Company
19th Jul 20183:30 pmRNSBlock listing Interim Review
28th Jun 20184:05 pmBUSResult of AGM
28th Jun 20187:00 amRNSAGM Statement
5th Jun 20183:58 pmRNSAnnual Report and Notice of AGM
4th Jun 20183:17 pmRNSTotal Voting Rights
4th May 201812:05 pmRNSTotal Voting Rights
9th Apr 20188:25 amRNSTotal Voting Rights
7th Mar 20187:00 amBUSFinal Results
5th Mar 20183:16 pmRNSHolding(s) in Company
5th Feb 20182:21 pmRNSTotal Voting Rights
29th Jan 20187:00 amRNSTrading Statement
19th Jan 20182:32 pmRNSBlock listing Six Monthly Return
22nd Nov 20174:53 pmRNSEmployee Share Plan and Directors' Dealing
20th Oct 20177:00 amRNSDirectorate Change
21st Sep 20173:30 pmRNSDirector/PDMR Shareholding
21st Sep 20173:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.